Related Experiment Video
Updated: Sep 18, 2025
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Influenza Vaccination During Pregnancy and Infant Influenza in the First 6 Months of Life
Ousseny Zerbo1, Sharareh Modaressi, Kristin Goddard
1Vaccine Study Center, Kaiser Permanente Northern California, Oakland, and the Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California.
Insights
Pregnant individuals vaccinated against influenza protect their infants from infection. Maternal vaccination reduced infant influenza by 44.4%, with greater protection when the vaccine was given in the second or third trimester.
Area of Science:
- Maternal and Child Health
- Vaccinology
- Infectious Disease Epidemiology
Background:
- Infant influenza poses a significant health risk during the first six months of life.
- Maternal influenza vaccination is a strategy to protect infants too young to be vaccinated.
Purpose of the Study:
- To assess the effectiveness of maternal influenza vaccination in preventing infant influenza during the first six months of life.
Main Methods:
- A cohort study of pregnant individuals and their infants was conducted.
- Cox regression analysis was used to compare influenza risk in infants based on maternal vaccination status.
- Vaccine effectiveness was calculated as 100% (1-adjusted Hazard Ratio).
Main Results:
- Maternal influenza vaccination was associated with a 44.4% reduction in infant influenza.
- Vaccine effectiveness varied by trimester: 11.3% (first), 51.5% (second), and 59.3% (third).
- Reductions were statistically significant when comparing first trimester vaccination to second and third trimesters.
Conclusions:
- Influenza vaccination during pregnancy significantly reduces infant influenza infection.
- Vaccination in the second and third trimesters offers greater protection to infants compared to first-trimester vaccination.
Objective:
To evaluate the effectiveness of influenza vaccination during pregnancy against influenza in infants during their first 6 months of life.
Methods:
We conducted a cohort study among pregnant individuals enrolled in Kaiser Permanente Northern California (KPNC) and their infants. We followed all infants from birth until the first occurrence of a polymerase chain reaction test result positive for influenza, the infant reached age 6 months, death, disenrollment from KPNC, or the end of the study on December 31, 2022. We used Cox regression to compare the hazard of influenza in infants whose mothers were vaccinated against influenza during pregnancy with those whose mothers were unvaccinated. Hazard ratios (HRs) were adjusted for calendar time, maternal sociodemographic and comorbidities. Vaccine effectiveness was calculated as 100% (1-adjusted HR). We evaluated the association between vaccination and infant influenza outcomes any time during pregnancy and by trimester of vaccination.
Results:
Of the 245,498 infants included in the study, 46.0% were born to vaccinated mothers. The incidence of influenza was lower among infants of vaccinated mothers than unvaccinated mothers (0.12% vs 0.30%). After adjusting for covariates, vaccination during pregnancy was associated with a reduction in infant influenza in any clinical setting by 44.4% (95% CI, 31.4-54.9%). Vaccination during the first trimester was associated with a reduction in infant influenza by 11.3%, a reduction of 51.5% during the second trimester, and a reduction of 59.3% during the third trimester. The differences in vaccine effectiveness estimates that compared the first and second trimesters ( P =.02) and compared the first and third trimesters ( P <.001 were statistically significant.
Conclusion:
Influenza vaccination during pregnancy was associated with a reduction in infant influenza infection by 44.4%. The reduction in infant influenza infection was greater when vaccination occurred in the second or third trimester, compared with the first trimester.
Related Concept Videos
01:51Vaccinations
01:22Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....